序号 |
标题 |
次数 |
作者 |
发布时间 |
81136 |
DOTA-dPEG2-R954,DOTA偶联R954衍生物 |
97 |
wyh |
2024-12-03 |
81137 |
3,6二氨基-1,2,4,5-四嗪-1,4-二氧化物(DATZO2);3,6-Diamino-1,2,4,5-tetrazine-1,4-dioxide |
94 |
WYQ |
2024-12-03 |
81138 |
3,6-双(3,5-二甲基-吡唑-1-酰基)-1,2,4-四嗪(BT);3,6-bis ( 3,5-dimethyl-pyrazol-1-oyl)-1,2,4,5-tetrazine |
112 |
WYQ |
2024-12-03 |
81139 |
3,6-双胍基-1,2,4,5-四嗪(DGTZ) |
135 |
WYQ |
2024-12-03 |
81140 |
氨基酸衍生物L-4-四嗪-苯丙氨酸 |
123 |
WYQ |
2024-12-03 |
81141 |
3,6-双(1-氢-1,2,3,4-四唑-5-氨基)-1,2,4,5-四嗪(BTATz) |
94 |
WYQ |
2024-12-03 |
81142 |
3-氨基-6-(3,5-二甲基吡唑基-1-基)-1,2,4-三唑[4,3-b]-1,2,4,5-四嗪(ADTTz) |
101 |
WYQ |
2024-12-03 |
81143 |
3-[(对甲氧基苯基)亚甲基腙]-6-(3,5-二甲基吡唑)-1,2,4,5-四嗪(DPMHT) |
116 |
WYQ |
2024-12-03 |
81144 |
3-[(3-甲氧基-4-羟基苯基)亚甲基腙]-6-(3,5-二甲基吡唑)-1,2,4,5-四嗪(DMPT) |
185 |
WYQ |
2024-12-03 |
81145 |
[Tc-99m]HYNIC-PEG(11)-Tz;[Tc-99m]标记联肼尼克酰胺多肽--PEG11-四嗪 |
92 |
WYQ |
2024-12-03 |
81146 |
maleimide-PEG-NHS ,马来酰亚胺-聚乙二醇-活性酯 |
86 |
wyh |
2024-12-03 |
81147 |
氨基聚乙二醇功能化的金纳米粒,AuNP-PEG-NH |
138 |
wyh |
2024-12-03 |
81148 |
Gd-DOTA修饰星形两亲性葡聚糖胶束 |
85 |
wyh |
2024-12-03 |
81149 |
IRFE-PEG-DOTA(IPD), 近红外二区(NIR II)有机染料 |
159 |
wyh |
2024-12-03 |
81150 |
[18F]FN-PEG4-Tz-TCO-GK-PEG4-5F7 ([18F]FN-GK-5F7) |
107 |
WYQ |
2024-12-03 |
81151 |
64Cu]Cu-NOTA-PEG7-H-Tz |
124 |
WYQ |
2024-12-03 |
81152 |
DOTA-PEG-DSPE ,DOTA-聚乙二醇-磷脂 |
91 |
wyh |
2024-12-03 |
81153 |
3,6-二氨基-1,2,4,5-四嗪(DATZ) |
83 |
WYQ |
2024-12-03 |
81154 |
DOTA-PEG(4)-BBN ;DOTA-四聚乙二醇-铃蟾肽 |
84 |
wyh |
2024-12-03 |
81155 |
3,6-二氨基-1,2,4,5-四嗪-1,4-二氧化物 |
131 |
WYQ |
2024-12-03 |
81156 |
1,6-二氢-1,2,4,5-四嗪化合物(1,6-Dihydro-1,2,4,5-Tetrazines) |
180 |
WYQ |
2024-12-03 |
81157 |
TCO-CC49 ,TCO功能化CC49抗体 |
112 |
wyh |
2024-12-03 |
81158 |
[111In]In-DOTA-PEG11-BisPy-Tz |
110 |
WYQ |
2024-12-03 |
81159 |
3,6-二烷基-1,2,4,5-四嗪(或-s-四嗪);3,6-dialkyl-1,2,4,5-tetrazines (or -s-tetrazines) |
98 |
WYQ |
2024-12-03 |
81160 |
3,6-二烷基-1,2,4,5-四嗪(或-s-四嗪);3,6-dialkyl-1,2,4,5-tetrazines (or -s-tetrazines) |
93 |
WYQ |
2024-12-03 |
81161 |
3,6-双(2-吡啶基)-1,2,4,5-四嗪(bptz);3,6-bis(2-pyridyl)-1,2,4,5-tetrazine |
104 |
WYQ |
2024-12-03 |
81162 |
(DOTA)5-decalysine , (DOTA)5-十氢赖氨酸 |
81 |
wyh |
2024-12-03 |
81163 |
3,6-dihydrazino-1,2,4,5-tetrazine(DHT) |
114 |
WYQ |
2024-12-03 |
81164 |
5-TAMRA-Tz;S-四嗪近红外花菁染料;5-TAMRA-tetrazine |
125 |
WYQ |
2024-12-03 |
81165 |
[64Cu]Cu-SarAr-Tz;(64)Cu标记四嗪放射性配体 |
193 |
WYQ |
2024-12-03 |
81166 |
DOTA-monoamide,DOTA-单酰胺复合物 |
98 |
wyh |
2024-12-03 |
81167 |
DOTA-PEG-RGD, DOTA-聚乙二醇-多肽 |
148 |
wyh |
2024-12-03 |
81168 |
DOTA-PEGn-Cys-VS ,单分散PEG偶联螯合剂DO |
103 |
wyh |
2024-12-03 |
81169 |
甲氧基DOTA ,MeO-DOTA |
197 |
wyh |
2024-12-03 |
81170 |
DOTA-BASS , DOTA偶联sst拮抗剂 |
185 |
wyh |
2024-12-03 |
81171 |
DOTA-phenylalanine,DOTA-苯丙氨酸 |
105 |
wyh |
2024-12-03 |
81172 |
DOTA−Lysine−Biotin, DOTA -赖氨酸-生物素 |
102 |
wyh |
2024-12-03 |
81173 |
DOTA-GA,螯合剂DOTA肽缀合物 |
127 |
wyh |
2024-12-03 |
81174 |
DOTA共轭二膦酸盐,DOTA-HBP |
115 |
wyh |
2024-12-03 |
81175 |
DOTA-神经介素n ,DOTA-Neuromedin N |
104 |
wyh |
2024-12-03 |
81176 |
tris-烯丙基-DOTA , tris-allyl-DOTA |
85 |
wyh |
2024-12-03 |
81177 |
6-(苄氧羰基)氨基-3-(甲硫基)-1,2,4-四嗪;6-(benzyloxycarbonyl)amino-3-(methylthio)-1,2,4,5-tetrazine |
103 |
WYQ |
2024-12-03 |
81178 |
6-(乙酰氨基)-3-(甲硫基)-1,2,4-四嗪;6-(acetylamino)-3-(methylthio)-1,2,4,5-tetrazine |
127 |
WYQ |
2024-12-03 |
81179 |
cFLFLFK-PEG-DOTA ;细胞特异性肽-聚乙二醇-DOTA |
71 |
wyh |
2024-12-03 |
81180 |
6-[(叔丁氧基羰基)氨基]-3-(甲硫基)-1,2,4-四嗪;6-[(tert-butyloxycarbonyl)amino]-3-(methylthio)-1,2,4,5-tetrazine |
108 |
WYQ |
2024-12-03 |